US HB4489 | 2009-2010 | 111th Congress
Status
Spectrum: Partisan Bill (Democrat 17-0)
Status: Introduced on January 21 2010 - 25% progression, died in chamber
Action: 2010-03-24 - Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 21 2010 - 25% progression, died in chamber
Action: 2010-03-24 - Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Text: Latest bill text (Introduced) [PDF]
Summary
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with requirements of this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply. Prohibits: (1) a pharmaceutical drug manufacturer or retail pharmacy from having a controlling interest in the PBM; or (2) the PBM from having a controlling interest in a retail pharmacy. Requires each carrier to certify PBM compliance annually. Prohibits OPM from permitting a carrier that has a controlling interest in a PBM to earn a profit from such interest with respect to an FEHBP contract. Sets forth requirements of PBM arrangements under the FEHBP, including regarding: (1) drug substitution restrictions; (2) PBM reimbursement of carriers; (3) sale by a PBM of utilization and claims data; (4) drug pricing and the basis for reimbursement; (5) provisions of an explanation of benefits to enrollees; (6) nondiscriminatory contracts regarding required participation; (7) OPM access to PBM contract information; (8) civil monetary penalties for making false statements or claims to the government; and (9) reports from drug manufacturers on average manufacturer prices for drugs each quarter.
Title
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Sponsors
Rep. Judy Chu [D-CA] | Rep. Lacy Clay [D-MO] | Rep. Gerald Connolly [D-VA] | Rep. Elijah Cummings [D-MD] |
Rep. Bill Delahunt [D-MA] | Rep. Lloyd Doggett [D-TX] | Rep. Steve Driehaus [D-OH] | Rep. Bob Filner [D-CA] |
Rep. Paul Hodes [D-NH] | Rep. Dennis Kucinich [D-OH] | Rep. Stephen Lynch [D-MA] | Rep. Jim Marshall [D-GA] |
Rep. James Moran [D-VA] | Rep. Eleanor Norton [D-DC] | Rep. Linda Sanchez [D-CA] | Rep. Peter Visclosky [D-IN] |
Rep. Anthony Weiner [D-NY] |
History
Date | Chamber | Action |
---|---|---|
2010-03-24 | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . | |
2010-03-24 | Subcommittee Consideration and Mark-up Session Held. | |
2010-02-23 | Subcommittee Hearings Held. | |
2010-02-12 | Referred to the Subcommittee on Federal Workforce, Post Office, and the District of Columbia. | |
2010-01-21 | Referred to the House Committee on Oversight and Government Reform. | |
2010-01-21 | Sponsor introductory remarks on measure. (CR E70-71) |
Subjects
Business records
Consumer affairs
Government employee pay, benefits, personnel management
Government operations and politics
Health care costs and insurance
Prescription drugs
Public contracts and procurement
Consumer affairs
Government employee pay, benefits, personnel management
Government operations and politics
Health care costs and insurance
Prescription drugs
Public contracts and procurement
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/111th-congress/house-bill/4489/all-info |
Text | https://www.congress.gov/111/bills/hr4489/BILLS-111hr4489ih.pdf |